Merus Labs International (Merus Labs International) Total Liabilities : $121.08 Mil (As of Mar. 2017)

View and export this data going back to 1996. Start your Free Trial

What is Merus Labs International Total Liabilities?

Merus Labs International's Total Liabilities for the quarter that ended in Mar. 2017 was $121.08 Mil.

Merus Labs International's quarterly Total Liabilities declined from Sep. 2016 ($135.51 Mil) to Dec. 2016 ($129.65 Mil) and declined from Dec. 2016 ($129.65 Mil) to Mar. 2017 ($121.08 Mil).

Merus Labs International's annual Total Liabilities declined from Sep. 2014 ($84.92 Mil) to Sep. 2015 ($62.71 Mil) but then increased from Sep. 2015 ($62.71 Mil) to Sep. 2016 ($135.51 Mil).

Merus Labs International Total Liabilities Historical Data

The historical data trend for Merus Labs International's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merus Labs International Total Liabilities Chart

Merus Labs International Annual Data

Trend

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Total Liabilities

Get a 7-Day Free Trial

58.38

41.70

84.92

62.71

135.51

Merus Labs International Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Total Liabilities	Get a 7-Day Free Trial															141.47	135.55	135.51	129.65	121.08

Merus Labs International Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Merus Labs International's Total Liabilities for the fiscal year that ended in Sep. 2016 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	44.666	+	(83.151	+	7.688
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	135.51

Total Liabilities	=	Total Assets (A: Sep. 2016 )	-	Total Equity (A: Sep. 2016 )
	=	286.379	-	150.874
	=	135.51

Merus Labs International's Total Liabilities for the quarter that ended in Mar. 2017 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	43.532	+	(70.013	+	7.532
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	121.08

Total Liabilities	=	Total Assets (Q: Mar. 2017 )	-	Total Equity (Q: Mar. 2017 )
	=	261.132	-	140.055
	=	121.08

Merus Labs International Total Liabilities Related Terms

Thank you for viewing the detailed overview of Merus Labs International's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Merus Labs International (Merus Labs International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merus Labs International Inc (NAS:MSLI) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.meruslabs.com

Merus Labs International Inc was incorporated on October 1, 2012 in British Columbia. The Company is a specialty pharmaceutical company. It acquires prescription medicines in various categories which include on patent but at maturity stage of product life cycle; branded generics; under promoted products; Niche market pharmaceuticals; and products with annual sales below critical threshold for large pharma. The Company competes with multinational pharmaceutical development corporations to small, single product companies that may limit their activities to a particular therapeutic area or region or territory.

Merus Labs International (Merus Labs International) Headlines

From GuruFocus

Update on Merus Labs International, Athabasca Minerals Inc, Enghouse Systems Limited, WiLAN Inc.

By Gordon Pape Gordon Pape • 06-22-2015

Slow Growth Ahead; Updates on Merus Labs International, Enghouse Systems, Athabasca Minerals

By Gordon Pape Gordon Pape • 10-05-2015

Merus Labs International: A Pharma Stock With Growth Potential

By Gordon Pape Gordon Pape • 03-30-2015